Gene Query: BAHCC1

Dataset Description Geneva Score
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 96.16
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 92.3
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 80.15
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 80.15
RNA sequencing analysis of human embryonic stem cells and axial progenitors 62.62
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 59.53
RNA-seq data from human lymphoma cell lines 59.15
ChIP-seq and RNA-seq from human lymphoma cell lines 59.15
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 58.33
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 58.33
BCL11B 55.08
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 53.4
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 53.4
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 49.23
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 48.25
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 48.25
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 46.25
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 42.79
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 42.06
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 40.84
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 39.86
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 39.34
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 38.87
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 38.0
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 37.63
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 36.91
RNAseq of T-ALL upon long non coding rna purturbation 36.46
Nrf2 regulated genes in A549 cells 34.97
Identification of Nrf2 regulated genes by RNA sequencing 34.97
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 34.84
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 34.68
A novel target of EZH1/2 for treatment of mantle cell lymphoma 34.62
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 34.17
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 34.17
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 33.26
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 32.31
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 32.27
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 32.14
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 31.61
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 31.23
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 31.23
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 30.97
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 30.97
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 30.03
Gene expression changes after LOC550643 silencing 29.81
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 29.67
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 29.67
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 28.16
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 27.51
MOF acetyl transferase regulates transcription and respiration in mitochondria 27.36
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 27.16
Mechanistic Model-Guided Study of Embryonic Morphogenesis 27.0
RNA-seq analysis of RALD iPSCs after in vitro differentiation 26.87
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 26.52
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 26.24
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 25.88
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 25.17
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 24.95
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 24.2
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 23.91
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 23.67
Tyrosine Kinase Inhibitor Cardiotoxicity 22.84
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 22.84
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 22.43
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 22.34
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 22.34
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 22.18
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 21.85
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 21.85
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 21.43
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 21.41
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 21.1
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 21.04
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 21.04
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 20.92
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 20.67
Silencing SPIB in attached and floating state of H1703 lung cancer cells 20.67
DART-seq: an antibody-free method for global m6A detection 20.52
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.22
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 20.13
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 20.09
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 19.99
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 19.93
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 19.93
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 19.59
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 19.56
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 19.54
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 19.54
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 19.5
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 19.31
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 19.2
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 19.14
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 18.51
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 18.19
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 18.13
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 18.08
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 18.04
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 17.98
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 17.91
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 17.8
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 17.24
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 17.13
RNAseq Analysis in glioblastoma cells treated with Mepazine 17.11
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 17.05
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.99
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 16.98
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 16.82
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 16.82
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 16.7
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 16.64
Gene expressions of H9s in different culture systems 16.42
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 16.33
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 16.19
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 16.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 16.15
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 16.0
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 15.96
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 15.94
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 15.91
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 15.86
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 15.46
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 15.19
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 15.17
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 14.89
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 14.88
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 14.72
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 14.68
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 14.68
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 14.52
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 14.43
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 14.18
RNA-seq analysis of gene expression patterns during hESC neural differentiation 14.12
hESC neural differentiation 14.12
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 14.07
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 13.93
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 13.85
Transcription control by the ENL YEATS domain in acute leukemia 13.84
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 13.84
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 13.74
Recovery and analysis of nascent RNA 13.72
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 13.72
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 13.69
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 13.35
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 13.16
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 13.15
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 13.15
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 13.1
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 13.1
Searching for target genes of miR-508/509/506/514 in HCT116 cells 13.01
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 12.99
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 12.93
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 12.86
12.83
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 12.77
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 12.68
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 12.6
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 12.57
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 12.55
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 12.54
NR2F2 study 12.54
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 12.51
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 12.51
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 12.3
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 12.25
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 12.25
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 12.24
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 12.24
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 12.23
RNA polymerase in pre-B-ALL cell lines 12.23
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 12.16
Global analysis of alternative splicing regulated by RBM10 12.13
Identification of long noncoding RNAs in T-ALL cell lines 12.04
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 12.03
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 12.0
RNA sequencing of BT142 and TS603 cell lines 11.98
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 11.98
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 11.95
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 11.88
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.88
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.88
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 11.87
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.84
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 11.7
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 11.64
Targeted enhancer activation by a subunit of the integrator complex 11.55
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 11.49
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 11.47
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 11.47
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 11.44
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 11.43
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.43
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 11.41
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 11.41
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 11.36
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 11.32
Genome-wide mapping of TEL-AML1 targets in acute leukemia 11.31
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 11.3
Human T-cell lymphoblastic lymphoma samples and control thymuses 11.3
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 11.29
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 11.26
ARID1A and ARID1B loss in HCT116 and TOV21G cells 11.24
RNA-sequencing in irradiated and normal A549 cells. 11.21
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 11.15
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 11.15
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 11.13
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.09
RNA-seq in transgenic cells 11.06
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 11.04
Nonpregnant and term pregnant human myometrial tissues 11.04
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.98
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.97
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 10.81
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 10.81
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 10.76
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 10.69
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 10.61
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 10.57
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 10.57
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 10.48
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 10.48
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 10.47
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 10.46
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 10.37
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.36
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 10.34
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.34
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 10.32
The DPYSL2 gene connects mTOR and schizophrenia 10.2
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 10.19
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.17
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 10.14
RNA-seq analysis of AML cells in response to ASLAN003 10.07
RNA-seq analysis of BAP1-depleted uveal melanoma cells 10.01
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 9.97
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 9.93
Transcriptome-wide identification of CELF2 functional targets in T cells 9.9
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 9.87
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 9.75
SETBP1-WT and SETBP1-G870S epigenetic landscapes 9.73
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 9.73
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 9.73
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.72
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 9.72
Altering cancer transcriptomes using epigenomic inhibitors 9.65
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.65
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 9.64
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 9.63
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 9.62
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 9.62
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.52
TCF7L1 knockdown in pancreatic cancer 9.51
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 9.46
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 9.46
SUV420H2 knockdown in PANC-1 9.45
A map of gene expression in neutrophil-like cell lines 9.41
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 9.4
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 9.4
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 9.39
Transcriptomic profile of human embryonic renal corpuscles 9.38
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.38
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 9.36
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.35
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 9.34
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 9.31
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.21
Co-regulation of splicing by Rbfox1 and hnRNP M 9.21
Transcriptome analysis of CNS leukemia 9.11
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 9.11
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 9.1
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 9.03
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 9.01
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.95
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 8.91
Inhibition of TNBC metastasis by Gpx1 8.83
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 8.81
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 8.8
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 8.78
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 8.68
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 8.67
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 8.64
Targeting EZH2 in MYCN-amplified Neuroblastoma 8.64
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 8.63
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 8.6
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 8.55
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 8.5
In situ CAPTURE of chromatin interactions by biotinylated dCas9 8.38
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 8.38
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 8.35
Tumor exosome integrins determine organotropic metastasis 8.26
RNA-seq of naive and primed ES cells (NHSM) 8.25
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 8.22
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 8.21
A prostate cancer chromatin interaction map 8.18
Paxillin regulates genomic networks in prostate cancer [C4-2] 8.1
Bone marrow derived human B cells [normal proB] 8.08
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.08
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.06
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 8.0
RNA-sequencing of human liver tissue 7.95
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 7.95
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.91
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 7.84
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 7.8
Gene Expression Profiling of SPOP Knocked Down Cell 7.78
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.77
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 7.76
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.74
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.73
LIN28A modulates splicing and gene expression programs in breast cancer cells 7.63
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 7.63
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 7.59
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.53
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 7.49
Differential gene expression profiles in imatinib-resistant cell lines 7.44
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 7.4
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 7.38
Effect of ILF3 on translation during homeostasis and the antiviral response 7.37
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 7.36
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 7.34
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 7.31
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.28
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 7.28
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 7.2
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 7.2
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 7.2
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 7.2
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.16
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 7.14
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 7.13
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 7.13
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 7.09
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 7.09
The pioneer factor CEBPA modulates vitamin D signaling 7.09
Transcriptome Profiling of Human Primary Monocytes 7.06
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 6.91
RNA-seq of cancer cell lines treated with T-025 6.9
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 6.84
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 6.83
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 6.76
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.76
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 6.75
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 6.73
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 6.73
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 6.7
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 6.66
Role of FGFR1 in neuronal devlopment 6.57
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 6.52
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 6.47
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.43
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.37
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.33
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.23
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 6.22
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.2
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 6.2
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.17
Non-coding regions are the main source of tumor-specific antigens 6.12
Non-coding regions are the main source of tumor-specific antigens [human] 6.12
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 6.12
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.12
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 6.06
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 6.05
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.01
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 6.0
mRNA recovered upon RNF219 IP. [RNA-IP] 5.96
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.85
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.85
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.76
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 5.74
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 5.71
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 5.63
HEK293 Heat-shock experiment 5.6
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 5.55
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 5.52
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 5.5
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 5.48
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 5.44
mRNA-Seq profiling of human developing kidney 5.39
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.33
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.33
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.26
Differentiation enhances Zika virus infection in neuronal brain cells 5.17
ARID1A and ARID1B loss in HCT116 cells 5.14
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.06
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.0
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 4.94
Ribosomal protein RPL26 is the principal target of UFMylation 4.92
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  4.8
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.79
RNA-seq in endometrial stromal tumors 4.78
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.73
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.72
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.69
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 4.66
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 4.66
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 4.58
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 4.52
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.35
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.29
FGF2 regulation of gene expression in stable inducible Neurons 4.22
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 4.19
Studying the selectivity of a small molecule Synucleozid on transcriptome 4.06
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.04
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.96
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 3.86
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.77
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.63
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.6
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.6
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.58
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 3.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.53
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.53
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.4
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.39
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 3.34
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.11
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.98
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.92
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.9
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.88
Dynamic 3D chromosomal landscapes in acute leukemia 2.85
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.85
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.76
Gene expression analysis upon mtDNA depletion 2.76
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.72
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.62
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.59
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.54
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 2.51
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.48
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.44
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.43
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.41
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.38
Oncogenic roles of ARID5B in T-ALL 2.38
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.3
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.28
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.22
Cell responses to dysregulated VZV-induced cell-cell fusion 2.21
RNA-seq of primary patient AML samples 2.14
BI Human Reference Epigenome Mapping Project 2.11
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.07
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.02
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.02
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.96
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 1.9
FOXP2's impact on the primate transcriptome 1.85
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.78
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.78
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.78
SOX11 knockdown in B-ALL cell lines 1.78
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.75
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.68
Functional astrocytes differentiated from hiPSCs 1.6
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.6
Patient-derived xenograft platform for metastatic melanoma 1.59
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 1.57
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.51
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.39
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.33
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.27
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.25
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.11
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.11
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.11
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 1.09
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.07
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.03
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.03
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.02
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.02
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.01
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.99
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.96
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 0.91
0.9
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.83
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.83
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 0.83
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.76
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.74
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.59
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.58
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.54
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.48
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.46
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.34
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.31
hNSCs siRNA NOVA2 0.3
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.3
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.28
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.26
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.24
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.23
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.16
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.16
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation